Dusa pharmaceuticals inc (DUSA)
Income statement / TTM
Sep'12Jun'12Mar'12Dec'11Sep'11Jun'11Mar'11Sep'10Jun'10
Product revenues

50,156

49,789

47,735

45,296

38,042

37,369

0

0

0

Cost of product revenues

7,764

7,668

7,361

6,921

6,141

6,511

0

0

0

GROSS MARGIN

42,391

42,121

40,373

38,374

31,900

30,857

0

0

0

Research and development

7,490

7,100

6,002

5,275

5,023

4,966

0

0

0

Marketing and sales

16,756

16,755

16,043

15,382

13,407

13,192

0

0

0

General and administrative

11,499

10,911

10,586

9,956

9,530

9,458

0

0

0

TOTAL OPERATING COSTS

35,746

34,766

32,631

30,614

27,960

27,618

0

0

0

INCOME FROM OPERATIONS

6,645

7,355

7,742

7,759

3,939

3,239

0

0

0

Other income

14

15

32

46

106

159

0

0

0

(Loss) gain on change in fair value of warrants

-2,826

1,444

-748

-1,013

-625

-3,352

0

0

0

(LOSS) INCOME FROM CONTINUING OPERATIONS

3,832

8,815

7,026

6,793

0

0

0

-

-

(LOSS) INCOME FROM DISCONTINUED OPERATIONS

-

-

560

526

0

0

0

-

-

NET (LOSS) INCOME

3,733

8,661

7,587

7,319

4,045

726

0

0

0

CONTINUING OPERATIONS

-0.06

0.09

-

-

0.14

0.02

-

-

-

DISCONTINUED OPERATIONS

-

-

-

-

-

0.03

-

-

-

BASIC NET (LOSS) INCOME PER SHARE

-0.06

0.09

-

-

0.14

0.05

-

0.00

0.01

CONTINUING OPERATIONS

-0.06

0.08

-

-

0.13

0.01

-

-

-

DISCONTINUED OPERATIONS

-

-

-

-

-

0.03

-

-

-

DILUTED NET (LOSS) INCOME PER SHARE

-0.06

0.08

-

-

0.13

0.04

-

0.00

0.01

WEIGHTED AVERAGE COMMON SHARES OUTSTANDING, BASIC

25,009

24,951

-

-

24,649

24,539

-

24,209

24,187

WEIGHTED AVERAGE COMMON SHARES OUTSTANDING, DILUTED

25,009

26,914

-

-

26,442

26,813

-

24,658

24,566

CONTINUING OPERATIONS

-

-

-0.01

-

-

-

-0.02

-

-

DISCONTINUED OPERATIONS

-

-

0.00

-

-

-

0.00

-

-

NET LOSS PER SHARE

-

-

-0.01

-

-

-

-0.02

-

-